U.S. markets open in 8 hours 12 minutes

Kaskela Law LLC Announces Shareholder Investigation of Eidos Therapeutics, Inc. and Encourages Investors to Contact the Firm – EIDX

PHILADELPHIA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Kaskela Law LLC is investigating Eidos Therapeutics, Inc. (“Eidos”) (EIDX) on behalf of the company’s shareholders. 

The investigation seeks to determine whether Eidos and/or the company’s officers and directors have violated the securities laws, and whether Eidos shareholders have been harmed as a result of such actions. 

Eidos shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740, or by email at skaskela@kaskelalaw.com, to discuss this investigation and their legal rights and options.  Additional information may also be found at http://kaskelalaw.com/case/eidos-thera/.

Kaskela Law LLC exclusively represents investors in securities, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.  This notice may constitute attorney advertising in certain jurisdictions.


D. Seamus Kaskela, Esq.
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740